Efficacy of Solithromycin (CEM-101) for Experimental Otitis Media Caused by Nontypeable Haemophilus influenzae and Streptococcus pneumoniae

about

Solithromycin (CEM-101): A New Fluoroketolide Antibiotic and Its Role in the Treatment of Gonorrhea.

P2860

Q38793951-1C4348D9-745E-4794-9FB1-91F88D4B0DF5

P2860

Efficacy of Solithromycin (CEM-101) for Experimental Otitis Media Caused by Nontypeable Haemophilus influenzae and Streptococcus pneumoniae

Item

http://www.wikidata.org/entity/Q37203789

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 11 July 2016

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Efficacy of Solithromycin (CEM ...... e and Streptococcus pneumoniae

@en

Efficacy of Solithromycin

@nl

type

Item

label

Efficacy of Solithromycin (CEM ...... e and Streptococcus pneumoniae

@en

Efficacy of Solithromycin

@nl

prefLabel

Efficacy of Solithromycin (CEM ...... e and Streptococcus pneumoniae

@en

Efficacy of Solithromycin

@nl

P1476

Efficacy of Solithromycin (CEM ...... e and Streptococcus pneumoniae

@en

P2093

M Figueira

http://www.w3.org/2001/XMLSchema#string

P Fernandes

http://www.w3.org/2001/XMLSchema#string

S I Pelton

http://www.w3.org/2001/XMLSchema#string

P2860

In vitro activity of CEM-101 against Streptococcus pneumoniae and Streptococcus pyogenes with defined macrolide resistance mechanisms

In vitro activity of telithromycin against Haemophilus influenzae at epithelial lining fluid concentrations

Role of complement in host defense against pneumococcal otitis media

CEM-101, a novel fluoroketolide: antimicrobial activity against a diverse collection of Gram-positive and Gram-negative bacteria.

Appropriate treatment of acute otitis media in the era of antibiotic resistance.

Treatment of acute otitis media in children under 2 years of age

Pharmacokinetics of solithromycin (CEM-101) after single or multiple oral doses and effects of food on single-dose bioavailability in healthy adult subjects.

Comparison of plasma, epithelial lining fluid, and alveolar macrophage concentrations of solithromycin (CEM-101) in healthy adult subjects.

Solithromycin Pharmacokinetics in Plasma and Dried Blood Spots and Safety in Adolescents.

Effect of antimicrobial treatment of acute otitis media on the daily disappearance of middle ear effusion: a placebo-controlled trial.

P304

5533-5538

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/AAC.00863-16

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-07-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27401563

http://www.w3.org/2001/XMLSchema#string

P932

4997842

http://www.w3.org/2001/XMLSchema#string

Efficacy of Solithromycin (CEM-101) for Experimental Otitis Media Caused by Nontypeable Haemophilus influenzae and Streptococcus pneumoniae

about

P2860

P2860

Efficacy of Solithromycin (CEM-101) for Experimental Otitis Media Caused by Nontypeable Haemophilus influenzae and Streptococcus pneumoniae

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P932